CHB - Hepatitis B in children

  • What's involved: Optimising the management of chronic hepatitis B (CHB) in children and young people: A phase 2 prospective study to evaluate the use of quantitative hepatitis B surface antigen as a marker to risk stratify patients
  • Take part: Open
  • Principal Investigator: Professor Stephen Ryder
Research Theme | Gastrointestinal & Liver | Open Trials

Optimising the management of chronic Hepatitis B (CHB) in children and young people:

A phase 2 prospective study to evaluate the use of quantitative Hepatitis B surface antigen as a marker to risk stratify patients.

What's involved

Optimising the management of chronic hepatitis B (CHB) in children and young people: A phase 2 prospective study to evaluate the use of quantitative hepatitis B surface antigen as a marker to risk stratify patients

Principal Investigator

Professor Stephen Ryder

Take part

Open
Back to all trials

Contact Us

NIHR Biomedical Research Centre: Nottingham
Research & Innovation
D Floor (via South Block)
Nottingham University Hospitals NHS Trust
Queen’s Medical Centre
Derby Road
Nottingham
NG7 2UH

Telephone: 0115 924 9924

Director: Professor Ian Hall

Hosted by

Nottingham University Hospitals Logo

Nottingham University Hospitals Logo

We are a partnership between Nottingham University Hospitals NHS Trust and the University of Nottingham, supported by NHS and academic partners in Nottingham and across the East Midlands.

Website by Volute